Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.89 | N/A | +0.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.89 | N/A | +0.56% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism about the company's performance. They acknowledged market challenges while emphasizing their commitment to innovation.
Management expressed satisfaction with the EPS performance despite the lack of revenue data.
They noted ongoing challenges in the market but highlighted strong product demand.
Abbott Labs reported a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and no guidance may lead to uncertainty among investors. The stock reaction is not available, but the cautious tone from management suggests they are navigating a challenging market environment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
INTEL CORP
Jul 14, 2009